Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-11-14 Sale | 2023-11-16 4:18 pm | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 20,000 | $39.43 | $788,670 | 179,269 (Direct) | View |
| 2023-10-17 Sale | 2023-10-17 7:28 pm | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 10,000 | $36.52 | $365,200 | 193,010 (Direct) | View |
| 2023-09-19 Sale | 2023-09-19 4:09 pm | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 10,000 | $39.1 | $390,980 | 203,010 (Direct) | View |
| 2023-08-29 Sale | 2023-08-31 5:35 pm | HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO | 30,000 | $42.69 | $1,280,730 | 983,666 (Direct) | View |
| 2023-08-22 Sale | 2023-08-23 5:08 pm | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 10,000 | $42.41 | $424,070 | 218,590 (Direct) | View |
| 2023-08-15 Sale | 2023-08-17 5:29 pm | HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO | 30,000 | $43.49 | $1,304,820 | 1,073,666 (Direct) | View |
| 2023-08-11 Sale | 2023-08-15 4:04 pm | HALOZYME THERAPEUTICS INC. | HALO | Daly James M Director | 20,000 | $43.73 | $874,520 | 20,503 (Direct) | View |
| 2023-07-25 Sale | 2023-07-27 4:03 pm | HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO | 30,000 | $43.09 | $1,292,750 | 1,163,666 (Direct) | View |
| 2023-07-18 Sale | 2023-07-19 4:10 pm | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 10,000 | $40.43 | $404,300 | 261,868 (Direct) | View |
| 2023-06-21 Sale | 2023-06-22 6:20 pm | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 10,000 | $36 | $360,000 | 159,416 (Direct) | View |
| 2023-04-18 Sale | 2023-04-19 6:07 pm | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 10,000 | $36 | $360,000 | 169,416 (Direct) | View |
| 2023-02-27 Sale(A) | 2023-04-19 6:01 pm | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 2,984 | $49.55 | $147,854 | 179,416 (Direct) | View |
| 2023-03-07 Sale | 2023-03-09 5:04 pm | HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO | 30,000 | $43.82 | $1,314,550 | 653,666 (Direct) | View |
| 2023-02-28 Sale | 2023-03-01 6:07 pm | HALOZYME THERAPEUTICS INC. | HALO | Henderson Jeffrey William Director | 20,000 | $48.11 | $962,200 | 39,045 (Direct) | View |
| 2023-02-27 Sale | 2023-02-28 4:59 pm | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 10,000 | $49.55 | $495,483 | 138,927 (Direct) | View |
| 2023-02-16 Sale | 2023-02-21 7:05 pm | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 2,878 | $49.26 | $141,770 | 233,165 (Direct) | View |
| 2023-02-16 Sale | 2023-02-21 7:00 pm | HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | 2,525 | $49.26 | $124,382 | 106,722 (Direct) | View |
| 2023-02-16 Sale | 2023-02-21 6:59 pm | HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO | 11,061 | $49.26 | $544,865 | 957,552 (Direct) | View |
| 2023-02-15 Sale | 2023-02-17 06:29 am | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 10,000 | $48.39 | $483,940 | 152,465 (Direct) | View |
| 2023-02-07 Sale | 2023-02-09 5:44 pm | HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO | 30,000 | $51.01 | $1,530,150 | 707,177 (Direct) | View |
| 2023-01-17 Sale | 2023-01-19 5:07 pm | HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO | 30,000 | $51.3 | $1,539,149 | 797,177 (Direct) | View |
| 2023-01-17 Sale | 2023-01-18 7:07 pm | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 10,000 | $50.46 | $504,590 | 143,137 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-11-14 Exercise | 2023-11-16 4:18 pm | N/A 2025-02-04 | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 20,000 | $0 | 179,269 (Direct) | View |
| 2023-11-14 Exercise | 2023-11-16 4:18 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 18,292 | $13.81 | 179,269 (Direct) | View |
| 2023-11-14 Exercise | 2023-11-16 4:18 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 1,708 | $16.78 | 179,269 (Direct) | View |
| 2023-10-17 Exercise | 2023-10-17 7:28 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 10,000 | $19.98 | 193,010 (Direct) | View |
| 2023-10-17 Exercise | 2023-10-17 7:28 pm | N/A 2030-02-10 | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 10,000 | $0 | 193,010 (Direct) | View |
| 2023-09-19 Exercise | 2023-09-19 4:09 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 10,000 | $19.98 | 203,010 (Direct) | View |
| 2023-09-19 Exercise | 2023-09-19 4:09 pm | N/A 2030-02-10 | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 10,000 | $0 | 203,010 (Direct) | View |
| 2023-08-29 Exercise | 2023-08-31 5:35 pm | N/A 2025-02-06 | HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO | 30,000 | $13.87 | 983,666 (Direct) | View |
| 2023-08-22 Exercise | 2023-08-23 5:08 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 1,925 | $18.41 | 218,590 (Direct) | View |
| 2023-08-22 Exercise | 2023-08-23 5:08 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 8,075 | $19.98 | 218,590 (Direct) | View |
| 2023-08-22 Exercise | 2023-08-23 5:08 pm | N/A 2028-02-14 | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 10,000 | $0 | 218,590 (Direct) | View |
| 2023-08-15 Exercise | 2023-08-17 5:29 pm | N/A 2025-02-06 | HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO | 30,000 | $13.87 | 1,073,666 (Direct) | View |
| 2023-07-25 Exercise | 2023-07-27 4:03 pm | N/A 2025-02-06 | HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO | 30,000 | $13.87 | 1,163,666 (Direct) | View |
| 2023-07-18 Exercise | 2023-07-19 4:10 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 10,000 | $18.41 | 261,868 (Direct) | View |
| 2023-07-18 Exercise | 2023-07-19 4:10 pm | N/A 2028-02-14 | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 20,000 | $0 | 261,868 (Direct) | View |
| 2023-07-18 Exercise | 2023-07-19 4:10 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 7,175 | $13.81 | 261,868 (Direct) | View |
| 2023-07-18 Exercise | 2023-07-19 4:10 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 2,825 | $8.11 | 261,868 (Direct) | View |
| 2023-06-21 Exercise | 2023-06-22 6:20 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 10,000 | $18.41 | 159,416 (Direct) | View |
| 2023-06-21 Exercise | 2023-06-22 6:20 pm | N/A 2028-02-14 | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 10,000 | $0 | 159,416 (Direct) | View |
| 2023-05-05 Option Award | 2023-05-09 6:27 pm | 2024-05-05 2033-05-05 | HALOZYME THERAPEUTICS INC. | HALO | Posard Matthew L. Director | 19,436 | $0 | 124,625 (Direct) | View |
| 2023-05-05 Option Award | 2023-05-09 6:24 pm | 2024-05-05 2033-05-05 | HALOZYME THERAPEUTICS INC. | HALO | Miyashita Akiko Moni Director | 19,436 | $0 | 25,642 (Direct) | View |
| 2023-05-05 Option Award | 2023-05-09 6:21 pm | 2024-05-05 2033-05-05 | HALOZYME THERAPEUTICS INC. | HALO | MATSUI CONNIE Director | 19,436 | $0 | 198,375 (Direct) | View |
| 2023-05-05 Option Award | 2023-05-09 6:19 pm | 2024-05-05 2033-05-05 | HALOZYME THERAPEUTICS INC. | HALO | Henderson Jeffrey William Director | 19,436 | $0 | 58,481 (Direct) | View |
| 2023-05-05 Option Award | 2023-05-09 6:16 pm | 2024-05-05 2033-05-05 | HALOZYME THERAPEUTICS INC. | HALO | Duncan Barbara Gayle Director | 19,436 | $0 | 20,624 (Direct) | View |
| 2023-05-05 Option Award | 2023-05-09 6:14 pm | 2024-05-05 2033-05-05 | HALOZYME THERAPEUTICS INC. | HALO | Daly James M Director | 19,436 | $0 | 51,874 (Direct) | View |
| 2023-05-05 Option Award | 2023-05-09 6:12 pm | 2024-05-05 2033-05-05 | HALOZYME THERAPEUTICS INC. | HALO | Connaughton Bernadette Director | 19,436 | $0 | 51,657 (Direct) | View |
| 2023-05-05 Option Award | 2023-05-09 6:09 pm | 2024-05-05 2033-05-05 | HALOZYME THERAPEUTICS INC. | HALO | BIZZARI JEAN-PIERRE Director | 19,436 | $0 | 78,186 (Direct) | View |
| 2023-04-18 Exercise | 2023-04-19 6:07 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 10,000 | $18.41 | 169,416 (Direct) | View |
| 2023-04-18 Exercise | 2023-04-19 6:07 pm | N/A 2028-02-14 | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 10,000 | $0 | 169,416 (Direct) | View |
| 2023-02-27 Exercise(A) | 2023-04-19 6:01 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 2,984 | $18.41 | 179,416 (Direct) | View |
| 2023-02-27 Exercise(A) | 2023-04-19 6:01 pm | N/A 2028-02-14 | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 2,984 | $0 | 179,416 (Direct) | View |
| 2023-03-07 Exercise | 2023-03-09 5:04 pm | N/A 2024-01-06 | HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO | 30,000 | $14.66 | 653,666 (Direct) | View |
| 2023-03-01 Gift | 2023-03-01 6:11 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO | 10,000 | $0 | 623,666 (Direct) | View |
| 2023-02-16 Exercise | 2023-02-21 7:05 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 6,112 | $0 | 233,165 (Direct) | View |
| 2023-02-16 Option Award | 2023-02-21 7:05 pm | 2024-02-16 2033-02-16 | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 65,902 | $0 | 233,165 (Direct) | View |
| 2023-02-16 Option Award | 2023-02-21 7:02 pm | 2024-02-16 2033-02-16 | HALOZYME THERAPEUTICS INC. | HALO | Snyder Mark Howard SVP, GENERAL COUNSEL | 74,139 | $0 | 74,139 (Direct) | View |
| 2023-02-16 Exercise | 2023-02-21 7:00 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | 5,094 | $0 | 106,722 (Direct) | View |
| 2023-02-16 Option Award | 2023-02-21 7:00 pm | 2024-02-16 2033-02-16 | HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | 82,377 | $0 | 106,722 (Direct) | View |
| 2023-02-16 Exercise | 2023-02-21 6:59 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO | 21,010 | $0 | 957,552 (Direct) | View |
| 2023-02-16 Option Award | 2023-02-21 6:59 pm | 2024-02-16 2033-02-16 | HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO | 260,859 | $0 | 957,552 (Direct) | View |
| 2023-02-15 Tax Withholding | 2023-02-17 06:29 am | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 1,170 | $49.2 | 152,465 (Direct) | View |
| 2023-02-15 Exercise | 2023-02-17 06:29 am | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 3,386 | $0 | 152,465 (Direct) | View |
| 2023-02-15 Tax Withholding | 2023-02-17 06:25 am | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | 621 | $49.2 | 9,005 (Direct) | View |
| 2023-02-15 Exercise | 2023-02-17 06:25 am | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | 1,254 | $0 | 9,005 (Direct) | View |
| 2023-02-15 Tax Withholding | 2023-02-17 06:20 am | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO | 6,892 | $49.2 | 649,901 (Direct) | View |
| 2023-02-15 Exercise | 2023-02-17 06:20 am | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO | 13,092 | $0 | 649,901 (Direct) | View |
| 2023-02-10 Tax Withholding | 2023-02-14 5:24 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 5,676 | $48.92 | 161,610 (Direct) | View |
| 2023-02-10 Exercise | 2023-02-14 5:24 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 16,016 | $0 | 161,610 (Direct) | View |
| 2023-02-10 Tax Withholding | 2023-02-14 5:21 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | 2,073 | $48.92 | 8,366 (Direct) | View |
| 2023-02-10 Exercise | 2023-02-14 5:21 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | 3,892 | $0 | 8,366 (Direct) | View |
| 2023-02-10 Tax Withholding | 2023-02-14 5:17 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO | 33,735 | $48.92 | 648,798 (Direct) | View |
| 2023-02-10 Exercise | 2023-02-14 5:17 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO | 64,075 | $0 | 648,798 (Direct) | View |
| 2023-02-07 Exercise | 2023-02-09 5:44 pm | N/A 2024-01-06 | HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO | 30,000 | $14.66 | 707,177 (Direct) | View |
| 2023-02-03 Option Award | 2023-02-07 4:06 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | Duncan Barbara Gayle Director | 1,188 | $0 | 1,188 (Direct) | View |
| 2023-01-17 Exercise | 2023-01-19 5:07 pm | N/A 2024-01-06 | HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO | 30,000 | $14.66 | 797,177 (Direct) | View |
| 2023-01-03 Tax Withholding | 2023-01-04 6:00 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | Snyder Mark Howard SVP, GENERAL COUNSEL | 2,804 | $55.13 | 27,640 (Direct) | View |
| 2023-01-03 Exercise | 2023-01-04 6:00 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | Snyder Mark Howard SVP, GENERAL COUNSEL | 7,611 | $0 | 27,640 (Direct) | View |